🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Prospective, exploratory, multicenter pilot study investigating the structu...
Status
Recruiting
Location
IRCCS Eugenio Medea / Associazione la Nostra Famiglia
Start Date
2025-07-07
Trial ID
NCT07095062
Treatments Being Tested
Abnormal gait is a common issue in children with CP. As a result of motor w...
Status
Completed
Location
Batterjee Medical College
Start Date
2020-09-02
Trial ID
NCT05136716
Treatments Being Tested
This is a Phase I, multicentre, single-dose, open-label study to assess the...
Status
Not Yet Recruiting
Location
Research Site
Start Date
2026-06-30
Trial ID
NCT07643870
Treatments Being Tested
Since Gruntzig successfully performed percutaneous coronary balloon angiopl...
Status
Not Yet Recruiting
Location
Nanjing First Hospital
Start Date
2026-01-01
Trial ID
NCT04104854
Treatments Being Tested
The purpose of this study is to evaluate how Aztreonam (ATM) and Avibactam ...
Status
Recruiting
Location
Rady Children's Hospital
Start Date
2023-04-18
Trial ID
NCT05639647
SCUBA divers and chamber inside attendants will undergo a brief hyperbaric ...
Status
Completed
Location
Intermountain Medical Center
Start Date
2011-07
Trial ID
NCT01430325
Treatments Being Tested
This is an open-label, multicenter, phase Ib/II study of the combination of...
Status
Terminated
Location
Huntsman Cancer Institute at the University of Utah
Start Date
2022-09-23
Trial ID
NCT05405309
Philadelphia-negative myeloproliferative neoplasms (MPNs) occur sporadicall...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-05-21
Trial ID
NCT06923670
Single arm, single site, open-label Phase II study of the effects of oral o...
Status
Recruiting
Location
Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
Start Date
2019-06-03
Trial ID
NCT03786796
Treatments Being Tested
The purpose of this study is to describe how women with BRCA1/2 mutations r...
Status
Recruiting
Location
Dana Farber Cancer Institute (Data Collection Only)
Start Date
2018-01-04
Trial ID
NCT03396341
Treatments Being Tested